Tetanus immunization among healthcare professionals: cross-sectional study in Turkey

Sayar, Merve Sefa; Akça, Mustafa; Aşan, Ali; Gümüş, Ali; Göktaş, Sibel Yorulmaz; Hakyemez, İsmail Necati; Dagli, Ozgur; Öztürk, Çınar

doi:10.3855/jidc.16787

Cited by 2 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, it was understood that the nurses had a significant lack of knowledge about booster doses. 22 There are different data on the vaccination attitude, knowledge level, and vaccination rate of HCWs in survey studies conducted with HCWs in different countries. 23–26 …”

Section: Discussionmentioning

confidence: 99%

Assessment of tetanus Immunization among healthcare workers in Mogadishu, Somalia

Doğan¹,

Alİ²,

Alİ³

et al. 2023

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Tetanus is still a major problem in sub-Saharan African countries. This study aims to evaluate tetanus disease and vaccine awareness among healthcare workers in Mogadishu. This descriptive, cross-sectional study was scheduled for January 2–7, 2022. A questionnaire consisting of 28 questions was applied in a face-to-face manner to 418 healthcare workers. Only health workers aged≥18 living in Mogadishu were included. Questions about sociodemographic characteristics, tetanus disease, and vaccines were developed. 71.1% of the participants were female, 72% were ˂25 years old, 42.6% were nursing students, and 63.2% had a university education. It was observed that 46.9% of the volunteers had an income level of <$250, and 60.8% resided in the city center. 50.5% of the participants received a tetanus vaccine in their childhood. Questions to determine participants’ level of knowledge about tetanus and the tetanus vaccine were responded to with an accuracy of between 44 and 77%. Although 38.5% of the participants reported that they were exposed to trauma at least once a day, the rate of those who had three or more doses of the vaccine was only 10.8%. On the other hand, 51.4% reported that they had received training about tetanus and vaccination. There was a significant difference ( p < .001) in terms of knowledge level among sociodemographic characteristics. The fear of side effects was the most important reason for not being vaccinated. Healthcare workers in Mogadishu have little awareness of tetanus disease and vaccines. Efforts to improve education and other factors will be sufficient to eliminate the disadvantage brought about by the socio-demographic structure.

show abstract

Section: Discussionmentioning

confidence: 99%

Assessment of tetanus Immunization among healthcare workers in Mogadishu, Somalia

Doğan¹,

Alİ²,

Alİ³

et al. 2023

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

show abstract

A Preliminary Study to Evaluate the Immune Response to a Booster Dose of the Adult Tetanus-Diphtheria Vaccine (Td) Available in Iran

Noorian,

Mottaghi-Dastjerdi,

Soltany-Rezaee-Rad

et al. 2024

Iran J Pharm Res

View full text Add to dashboard Cite

Background: Despite the availability of tetanus-diphtheria (TD) vaccines in Iran, the seroconversion rate of these products as a booster dose is unknown. Objectives: This study evaluates the seroconversion rate of the Iranian Td vaccine in adults who have not been vaccinated in the past decade. Methods: In this study, 20 adult volunteers aged 18 to 60 who had not received the Td vaccine in the past decade received a booster dose of the Iranian Td vaccine. Twenty-eight days after vaccination, the seroconversion rate was evaluated using the ELISA method. Vaccine adverse events were monitored at three time points after vaccination. Results: Seroconversion rates with the Iranian Td vaccine boosters were 75% and 90%, respectively, based on a 4-fold increase in anti-tetanus toxoid antibody titers and a 2- and 4-fold combination. Significant associations were found between the demographic data, specifically female gender and age 43 years and older, with seroconversion rates. Injection-site pain was the most common adverse reaction, with a frequency of 35%. No adverse events were reported between one week and one month after vaccination. Conclusions: Results showed that a booster dose of the Iranian Td vaccine produced a protective titer (> 0.1 IU/mL) and a long-term protective titer (> 1.0 IU/mL) in 100% of participants. The seroconversion rate of the Iranian Td vaccine was comparable to other common tetanus vaccines, including Tenivac®, Adacel®, Infanrix®, Tetavax®, and Vacteta®. The proportion of suitable candidates for plasma donation, based on minimum (2 IU/mL) and maximum (10 IU/mL) anti-tetanus toxoid antibody titers, was 100% and 45%, respectively.

show abstract

Tetanus immunization among healthcare professionals: cross-sectional study in Turkey

Cited by 2 publications

References 12 publications

Assessment of tetanus Immunization among healthcare workers in Mogadishu, Somalia

Assessment of tetanus Immunization among healthcare workers in Mogadishu, Somalia

A Preliminary Study to Evaluate the Immune Response to a Booster Dose of the Adult Tetanus-Diphtheria Vaccine (Td) Available in Iran

Contact Info

Product

Resources

About